Kori, S., Zhang, J., Kellerman, D., Armer, T., & Goadsby, P. (2013). Sustained pain relief with dihydroergotamine in migraine is potentially due to persistent binding to 5-HT1B and 5-HT1D receptors. Springer.

Kori, S., J. Zhang, D. Kellerman, T. Armer, and P. Goadsby. Sustained Pain Relief With Dihydroergotamine in Migraine Is Potentially Due to Persistent Binding to 5-HT1B and 5-HT1D Receptors. Springer, 2013.

Kori, S., et al. Sustained Pain Relief With Dihydroergotamine in Migraine Is Potentially Due to Persistent Binding to 5-HT1B and 5-HT1D Receptors. Springer, 2013.